Is MCM8 rs16991615 associated with later natural menopause and ovarian reserve biology?

The minichromosome maintenance 8 (MCM8) gene is a critical regulator of female reproductive longevity, with the rs16991615 single nucleotide polymorphism (SNP) serving as a primary genetic modifier of ovarian aging.

Clinical evidence and ovarian reserve markers

• Large-scale genome-wide association studies (GWAS) demonstrate that the minor allele of the rs16991615 missense variant (E341K) is strongly associated with a delayed age at natural menopause.
• Each copy of this minor allele shifts the age of menopause onset later by approximately 0.9 to 1.1 years in women of European ancestry, and up to 14 months in other replicated cohorts.
• This genetic variant serves as a quantitative modifier of ovarian reserve biology; carriers of the minor allele exhibit significantly higher age-adjusted levels of anti-Müllerian hormone (AMH) and increased antral follicle counts (AFC) on ultrasound.

Mechanistic pathways of follicular depletion

• The MCM8 gene encodes a subunit of the MCM8-MCM9 complex, which is essential for meiotic homologous recombination and double-strand break repair in oocytes.
• The rs16991615 polymorphism modulates the efficiency of this DNA repair pathway during gametogenesis and follicle recruitment.
• Impaired homologous recombination leads to unrepaired double-strand breaks, activating intracellular checkpoints that trigger oocyte apoptosis and subsequently accelerate the depletion of the ovarian reserve.

Bottom line

• The MCM8 rs16991615 polymorphism is a robust, genome-wide significant genetic determinant of ovarian reserve and menopausal timing, where the minor allele preserves the follicular pool and delays natural menopause by approximately one year per copy by optimizing meiotic DNA double-strand break repair.